Reduction of Estrogenic Activity in Wastewater Following Treatment with Ferrate

Authors: Srisawat, Ponsawat; Streiffer, Adam B.; Barbeau, Deborah N.; Wiese, Thomas E.; Grimm, Deborah; Skaggs, Brady K.; Englande, Andrew J.; Reimers, Robert S.

Source: Proceedings of the Water Environment Federation, WEFTEC 2010: Session 51 through Session 60 , pp. 4102-4110(9)

Publisher: Water Environment Federation

Buy & download fulltext article:


Price: $17.50 plus tax (Refund Policy)


The removal efficiency of ferrate (Fe(VI)) on endocrine disrupting compounds in secondary effluent was investigate. Biological treatment process is able to decrease estrogenic activity in wastewater to 99.6 ng E2 equivalent/L, or decreased 46.6% . After chlorination, estrogenic activity in secondary effluent is increased to 128.63 ng E2 equivalent/L, or increased 29.14%. When treat secondary effluent with ferrate, maximum EDCs deactivation efficiency of 61% were obtained. Optimum dose of ferrate at 6 ppm is able to deactivated 54.18 % of estrogenic activity from secondary effluent. The increased concentration of organic matter in secondary effluent decreases percent EDCs deactivation to 23.7 for ferrate when its concentration went up from 11 to 20mg/L of TOC.
More about this publication?
  • Proceedings of the Water Environment Federation is an archive of papers published in the proceedings of the annual Water Environment Federation® Technical Exhibition and Conference (WEFTEC® ) and specialty conferences held since the year 2000. These proceedings are not peer reviewed.

    WEF Members: Sign in (right panel) with your IngentaConnect user name and password to receive complimentary access.
  • Subscribe to this Title
  • Membership Information
  • About WEF Proceedings
  • WEFTEC Conference Information
  • ingentaconnect is not responsible for the content or availability of external websites



Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page